Genome Editing & T-Cells

Genome editing technologies enable the editing of genes to create or correct mutations or express genes of interest. Here is the latest research on genome editing in T- cells and their application in human diseases such as adoptive T-cell immunotherapy for cancer.

July 9, 2020
Case Report

BISHOP-KOOP modification technique following proximal jejunal anastomosis: A case report

Annals of Medicine and Surgery
Vicky S Budipramana, Putu Ayu Saraswati
July 12, 2020

Optogenetics and CRISPR: A New Relationship Built to Last

Methods in Molecular Biology
Jan MathonyDominik Niopek
July 10, 2020
Open Access

Gene editing

Nature Biotechnology
July 10, 2020

A Drosophila model of Pontocerebellar Hypoplasia reveals a critical role for the RNA exosome in neurons

PLoS Genetics
Derrick J MortonAnita H Corbett
July 9, 2020
Review
Open Access

The present and potential future methods for delivering CRISPR/Cas9 components in plants

Journal, Genetic Engineering & Biotechnology
Dulam SandhyaAnshu Alok
July 11, 2020

Cleaving DNA by nanozymes

Journal of Materials Chemistry. B, Materials for Biology and Medicine
Ruiqin Fang, Juewen Liu
July 9, 2020

Efficient CRISPR-Cas9-Mediated Gene Ablation in Human Keratinocytes to Recapitulate Genodermatoses: Modeling of Netherton Syndrome

Molecular Therapy. Methods & Clinical Development
Victoria GálvezFernando Larcher
July 12, 2020

The novel insight into the outcomes of CRISPR/Cas9 editing intra- and inter-species

International Journal of Biological Macromolecules
Jiasong ChangQingyou Xia
July 10, 2020

Rewired signaling network in T cells expressing the chimeric antigen receptor (CAR)

The EMBO Journal
Rui DongXiaolei Su
July 14, 2020

Translational Toxicology in Zebrafish

Current Opinion in Toxicology
Tamara TalPamela J Lein
July 8, 2020
Comment / Editorial
Open Access

Science Runs and the Debate Brakes: Somatic Gene-Editing as a New Tool for Gender-Specific Medicine in Alzheimer's Disease

Brain Sciences
Pamela TozzoLuciana Caenazzo
July 9, 2020
Review

Hemophilia gene therapy-New country initiatives

Haemophilia : the Official Journal of the World Federation of Hemophilia
Ulrike M ReissTsukasa Ohmori
July 8, 2020
Review
Open Access

Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?

Genes
Regina MirgayazovaEmil Bulatov
July 8, 2020
Review
Open Access

Cystic Fibrosis: Overview of the Current Development Trends and Innovative Therapeutic Strategies

Pharmaceutics
Fahad A AlmughemAbdullah A Alshehri
July 8, 2020
Review
Open Access

Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing

Cells
Muhammad NaeemIrshad Ahmad
July 9, 2020
Preprint

Screening and testing for a suitable untransfected cell line for SARS-CoV-2 studies

BioRxiv : the Preprint Server for Biology
July 8, 2020
Review
Open Access

MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy

Cancers
Annelisa M CornelStefan Nierkens

Sign up to follow this feed and discover related papers.

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Alzheimer's Disease: RNA Sequencing

RNA sequencing is used to reveal the presence and quantity of RNA in a given sample. In this feed, RNA sequencing investigates the genetic and molecular mechanisms related to the pathophysiology of Alzheimer's disease (AD). Here are the latest discoveries pertaining to RNA sequencing and this disease.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

© 2020 Meta ULC. All rights reserved
/feed-previews/genome-editing-t-cells/bd00f2ee-9174-47d6-911b-1058f33fcf8e